Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US17347989Application Date: 2021-06-15
-
Publication No.: US12144892B2Publication Date: 2024-11-19
- Inventor: Shinji Okada
- Applicant: TAIHO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2017-026203 20170215
- Main IPC: A61K9/16
- IPC: A61K9/16 ; A61K31/04 ; A61K31/47

Abstract:
An object of the present invention is to provide a pharmaceutical composition which has excellent stability, disintegratability, and absorbability, is easily prepared, and contains 4-(2-fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide or a pharmaceutically acceptable salt thereof and a cyclodextrin derivative. The present invention relates to a pharmaceutical composition containing 4-(2-fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide or a pharmaceutically acceptable salt thereof and hydroxypropyl-β-cyclodextrin.
Public/Granted literature
- US12102719B2 Pharmaceutical composition Public/Granted day:2024-10-01
Information query